Evaluation of larval surface antigens from infective larvae of Strongyloides venezuelensis for the serodiagnosis of human strongyloidiasis.
Bruna Barroso GomesWilliam Henry Roldan GonzalesDirce Mary Correa MeiselRonaldo César Borges GryschekFabiana Martins de PaulaPublished in: Revista do Instituto de Medicina Tropical de Sao Paulo (2023)
Serodiagnosis of strongyloidiasis is usually performed by ELISA for the detection of IgG antibodies due to its high sensitivity and practicality, but its main limitation is a constant source of S. stercoralis antigens. The use of S. venezuelensis as a heterologous source of antigens has facilitated several published studies on the serodiagnosis and epidemiology of human strongyloidiasis. The main objective of this study was to evaluate the diagnostic accuracy of surface cuticle antigens of infective larvae of S. venezuelensis extracted with CTAB detergent (L3-CTAB) in comparison with soluble somatic extracts (L3-SSE) using a panel of sera from immunocompetent and immunocompromised individuals, at three different cut-offs. ROC curve analysis showed that L3-CTAB had an AUC of 0.9926. At the first cut-off value (OD 450 nm = 0.214), sensitivity and specificity were 100% and 90.11%, respectively, with a diagnostic accuracy of 0.93. At a second cut-off value (OD 450 nm = 0.286), sensitivity and specificity were 70% and 100%, respectively, with a diagnostic accuracy of 0.91. However, at an alternative third cut-off value (OD 450 nm = 0.589), sensitivity and specificity were 95% and 97.8%, respectively, with a diagnostic accuracy of 0.97. Using L3-CTAB as an antigenic source, the seropositivity rate in immunocompromised patients was 28.13% (9/32) whereas a seropositivity rate of 34.38% (11/32) was found when L3-SSE was used in ELISA. Therefore, the L3-CTAB is simple and practical to obtain and was found to be highly sensitive and specific.
Keyphrases
- endothelial cells
- dendritic cells
- end stage renal disease
- photodynamic therapy
- aedes aegypti
- ejection fraction
- induced pluripotent stem cells
- chronic kidney disease
- newly diagnosed
- drosophila melanogaster
- pluripotent stem cells
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- risk factors
- immune response
- patient reported outcomes
- high resolution
- intensive care unit
- respiratory failure
- dna methylation
- simultaneous determination
- living cells
- sensitive detection
- molecularly imprinted